Literature DB >> 3012601

Differential antagonism of diazepam-induced loss of the righting response.

J M Witkin, J E Barrett, J M Cook, P Larscheid.   

Abstract

Ethyl-beta-carboline-3-carboxylate (beta-CCE), inosine and Ro 15-1788 are antagonists of several actions of the benzodiazepines. These compounds can be differentiated, however, according to their ability to reverse the loss of the righting response induced by diazepam. Ro 15-1788 completely reversed effects of diazepam on the righting response of pigeons and squirrel monkeys but was ineffective against comparable effects produced by pentobarbital. Pretreatment with Ro 15-1788 protected against diazepam-induced righting loss. Neither inosine nor beta-CCE reversed diazepam-induced righting loss or acted prophylactically against this effect. Since beta-CCE has been characterized as an inverse agonist at the benzodiazepine receptor, the absence of antagonism we report would suggest that beta-CCE lacks specific pharmacological activity which opposes suppression of the righting response by diazepam. Research with these preferentially-acting antagonists may lead to the development of anxiolytics devoid of the sedative-hypnotic properties inherent in the drugs currently in a clinical use.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012601     DOI: 10.1016/0091-3057(86)90443-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  1 in total

1.  Ethyl β-Carboline-3-Carboxylate Increases Cervical Cancer Cell Apoptosis Through ROS-p38 MAPK Signaling Pathway.

Authors:  Hu-Nan Sun; Dan-Ping Xie; Chen-Xi Ren; Xiao-Yu Guo; Hui-Na Zhang; Wan-Qiu Xiao; Ying-Hao Han; Yu-Dong Cui; Taeho Kwon
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.